This is BrainsWay’s global website. The website includes information on clinical indications that were not cleared by the FDA and are considered investigational by the U.S. medical device regulations. The FDA cleared BrainsWay D treatment of Major Depression in patients who failed to respond to one or more anti-depressants in the current episode.
BrainsWay is ushering in a new era of brain disorder treatment. Through ongoing investment in R&D and in research initiatives ranging from large-scale multicenter trials to personalized medicine studies, BrainsWay represents the next-generation of treatments for depression, OCD, and other brain disorders, achieving outcomes not thought possible with traditional medical solutions.
*See response and remission rates in the MDD and OCD treatment pages
Major Depressive Disorder is a neuropsychiatric disorder that is expressed in emotional, physiological and behavioral effects.
BrainsWay Introduces the First FDA Cleared (De-Novo) Non-invasive Medical Device for the Treatment of OCD
Tobacco smoking is the leading cause of preventable death in developed countries. Smoking is not merely a bad
Post-traumatic stress disorder (PTSD) is an extreme anxiety response to a life-threatening situation, which often manifests as a
Neuropathy is common in the diabetic population, affecting approximately 50% of patients with long-lasting diseases. The most common
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in a person’s
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are
Autism is a complex developmental disability that typically appears during the first three years of life and is
Multiple Sclerosis (MSc) is an inflammatory demyelinating condition of the central nervous system that is mostly considered to
Anti-psychotic medications are often effective for the positive symptoms of schizophrenia, and allow many patients to lead normal
Parkinson’s disease is a degenerative disorder of the central nervous system, which progresses slowly and is characterized by
YEARS OF EXPERIENCE
Regain back your confidence and learn more about BrainsWay’s groundbreaking technology.
Take Part in an FDA Approved Study for Major Depressive Disorder (MDD) with the latest Deep TMS Technology
About BrainsWay Innovative
Take Part in an FDA Approved Study for MDD with the latest Deep TMS Technology by BrainsWay
About BrainsWay treatment
This book chapter describes the biological and physical components that participate in the effects of Brainsway®’s Deep TMS (Transcranial Magnetic